Ensysce Biosciences, Inc. (NASDAQ: ENSC) announced that the Food and Drug Administration provided written responses approving the company's proposed manufacturing ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE